NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle declared a quarterly dividend on Thursday, July 26th. Shareholders of record on Friday, September 14th will be given a dividend of $0.335 per share on Monday, October 1st. This represents a $1.34 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date is Thursday, September 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) issued its quarterly earnings data on Tuesday, August, 7th. The specialty chemicals company reported $1.36 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.28 by $0.08. The specialty chemicals company had revenue of $853.87 million for the quarter, compared to analyst estimates of $799.49 million. Albemarle had a return on equity of 14.51% and a net margin of 10.17%. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, November, 14th 2018. View Earnings Estimates for Albemarle.

Albemarle updated its FY18 earnings guidance on Tuesday, August, 7th. The company provided earnings per share guidance of $5.30-5.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.26. The company issued revenue guidance of $3.3-3.5 vln, compared to the consensus revenue estimate of $3.32 billion.

21 brokerages have issued 12-month price objectives for Albemarle's stock. Their forecasts range from $106.00 to $157.00. On average, they anticipate Albemarle's share price to reach $133.2506 in the next year. This suggests a possible upside of 40.5% from the stock's current price. View Analyst Price Targets for Albemarle.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 hold ratings and 19 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Sinopec Shanghai Petrochemical (SHI), Hexcel (HXL), PolyOne (POL), Trinseo (TSE), Rogers (ROG), Kraton (KRA), A Schulman (SHLM), AdvanSix (ASIX), Cereplast (CERPQ) and ForceField Energy (FNRG).

Headlines about ALB stock have been trending somewhat positive this week, Accern reports. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Albemarle earned a daily sentiment score of 0.15 on Accern's scale. They also gave headlines about the specialty chemicals company an impact score of 47.31 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for Albemarle.

Albemarle's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.50%), Jennison Associates LLC (6.62%), Bank of New York Mellon Corp (4.88%), Baillie Gifford & Co. (2.36%), Iridian Asset Management LLC CT (1.83%) and Global X Management Co LLC (1.43%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Baird Financial Group Inc., FMR LLC, Dividend Assets Capital LLC, Bank of New York Mellon Corp, Artisan Partners Limited Partnership, BlackRock Inc. and Los Angeles Capital Management & Equity Research Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Matthew Juneau. View Insider Buying and Selling for Albemarle.

ALB stock was acquired by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Jennison Associates LLC, Advisors Asset Management Inc., Rovida Advisors Inc., Sei Investments Co., Joho Capital LLC, Federated Investors Inc. PA and Handelsbanken Fonder AB. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $94.84.

Albemarle has a market capitalization of $10.35 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700.